Investor · El Segundo, CA

Lukasz Gottwald

Open Lukasz in the network graph →

Filings

14

SEC Form D

Connections

45

co-filers

Capital

$46.7M

across filings

Active

May 2014

to Nov 2019

Most-connected co-filers (45)

Danny Stepper · El Segundo, CA9 shared Bruce Booth · Cambridge, MA8 shared Jesus Delgado-Jenkins · El Segundo, CA8 shared 22Nw, LP · Seattle, WA5 shared 22Nw Fund GP, LLC · Seattle, WA5 shared Lance Collins · Long Beach, CA5 shared David A. Bree · Grand Cayman, Cayman Islands5 shared Anabatic Investment Partners, LLC · Oakbrook Terrace, IL4 shared Steven P. Miller · Cincinnati, OH4 shared Robert Carpenter · Cambridge, MA4 shared Cornelis Been · Cambridge, MA4 shared Steven E. Hall · Cambridge, MA4 shared Renee Karalian · El Segundo, CA4 shared Lawrence Spielman · El Segundo, CA4 shared Thomas E. Lynch · Boca Raton, FL4 shared Cynthia Schwarzkopf · Princeton, NJ4 shared Barry Belmont · Princeton, NJ4 shared Khaled El-Marsafy · Princeton, NJ4 shared Talal Al-Bahar · Princeton, NJ4 shared Clinton Pagano, Sr · Princeton, NJ4 shared Timur Tillyaev · Princeton, NJ4 shared Michael Ameen · Princeton, NJ4 shared Byrum Teekell · Princeton, NJ4 shared Paul Stahlin · Princeton, NJ4 shared

Recent filings (14)

Lysosomal Therapeutics, Inc.Nov 2019 · 18 co-filers$3.0M Viking Partners Fund IV-Q, LLCFeb 2019 · 5 co-filers$57.7M Viking Partners Fund IV-Q, LLCFeb 2019 · 5 co-filers$57.7M Lysosomal Therapeutics, Inc.Jan 2017 · 18 co-filers$26.1M Lysosomal Therapeutics, Inc.Oct 2016 · 17 co-filers$6.0M Core Nutrition, LLCMay 2016 · 19 co-filers$19.5M Core Nutrition, LLCApr 2016 · 16 co-filers$19.5M Core Nutrition, LLCDec 2015 · 16 co-filers$15.0M Core Nutrition, LLCApr 2015 · 16 co-filers$14.5M Viking Partners Fund III, LLCFeb 2015 · 5 co-filers$32.1M Lysosomal Therapeutics, Inc.Feb 2015 · 18 co-filers$20.0M Viking Partners Fund III-Q, LLCFeb 2015 · 5 co-filers$51.8M Lysosomal Therapeutics, Inc.May 2014 · 6 co-filers$4.8M Core Nutrition, LLCFeb 2014 · 8 co-filers$10.0M Core Nutrition, LLCFeb 2014 · 8 co-filers$10.0M

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Lukasz in the interactive graph →